Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at durvalumab for non small cell lung cancer (PACIFIC-4)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with non small cell lung cancer (NSCLC) who:

  • can’t have surgery to remove the lung cancer, or have chosen not to have an operation

  • are going to have stereotactic ablative radiotherapy (SABR) instead of surgery for lung cancer

It is for people who have an early stage (stage 1 or stage 2) NSCLC.

Recruitment start: 17 May 2019

Recruitment end: 5 April 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Kevin Franks

Supported by

Astra Zeneca

Last reviewed: 12 October 2024

CRUK internal database number: 16043

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.